Measuring AMH hormone levels in healthy girls
Treatments studied
This study measures a hormone called AMH in girls before and after puberty. It’s done while participants have a routine outpatient surgery, to better understand what AMH levels look like in healthy children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a girl or female between birth and age 18
- You are having a planned, routine outpatient surgery (not an all-day hospital stay)
- The surgery must be one of these: hernia repair, removal of a benign (non-cancer) lump, or laparoscopic gallbladder removal
- You have not been diagnosed with certain hormone or fertility-related conditions (like Turner syndrome, hormone disorders, insulin-dependent diabetes, or autoimmune disorders)
- You have not had cancer or any cancer treatments (chemo, radiation, or stem-cell transplant), and you have not had an ovary removed
- You are not pregnant, and you are not having a non-routine outpatient procedure (for example: central line placement, Supprelin placement/removal, breast mass removal, or feeding tube placement)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a blood test called AMH (anti-Müllerian hormone) is used in people being seen for PCOS or POI (early ovarian failure). The goal is to understand whether AMH measurements are useful for care in clinics and fertility treatment settings.
This study looks at how a hormone called AMH changes during breast cancer treatment to help predict how well your ovaries are working as you approach menopause. It may help doctors better understand fertility and ovarian health for women in your situation.
This early study looks at how certain “male-type” hormones and brain signals (measured through hormone patterns during the day and night) work in adolescent girls with high androgen levels. It may help researchers better understand causes like PCOS and related hormone timing differences.
This registry study is for people who have stopped getting periods due to a condition called functional hypothalamic amenorrhea, which may be linked to low estrogen and ovulation problems. Researchers want to track hormone patterns over time to better understand how the condition develops.
This study looks at whether a blood test (a hormone marker) can predict a child’s future risk of infertility after cancer treatment. If it works, it could help families and doctors plan earlier fertility and puberty-related care.
This study looks at whether a hormone level measured inside the fluid around eggs (follicular fluid) can predict whether embryos have the correct number of chromosomes. It may help clinics choose which embryos are more likely to be healthy.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.